⌘K

Login Start Free

Home/Filings/4/0001415889-24-018159

4//SEC Filing

Vig Pamela 4

Accession 0001415889-24-018159

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 5:15 PM ET

Size

9.2 KB

Accession

0001415889-24-018159

Insider Transaction Report

Form 4

Period: 2024-06-24

Mirum Pharmaceuticals, Inc.MIRM

Chief Scientific Officer

Transactions

Sale
Common Stock
2024-06-24$34.00/sh−30,559$1,039,006→ 27,406 total
Exercise/Conversion
Common Stock
2024-06-24$2.94/sh+30,559$89,721→ 57,965 total
Exercise/Conversion
Stock Option (right to buy)
2024-06-24−30,559→ 125,691 total
Exercise: $2.94Exp: 2029-03-11→ Common Stock (30,559 underlying)

Holdings

Common Stock
(indirect: By Trust)
75,000

Footnotes (2)

[F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted in March 2024.
[F2]The stock option is fully vested.

Documents

1 file

4
form4-06252024_090650.xmlPrimary

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780069

Filing Metadata

Form type: 4
Filed: Jun 24, 8:00 PM ET
Accepted: Jun 25, 5:15 PM ET
Size: 9.2 KB

View on SEC.gov